Stay updated with breaking news from Scott Snapper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drs Peter Higgins and Jean-Frederic Colombel discuss exciting new evidence in Crohn's disease research that may help in identifying those at risk before disease starts and pave the way for a vaccine.
News Category Global Banking & Finance Reviews Pandion Therapeutics Announces Positive Top-Line Phase 1a Clinical Data Showing PT101 was Well-Tolerated and Selectively Expanded Regulatory T cells -Phase 1a trial achieved primary objective of safety and tolerability -PT101 induced potent and selective expansion of regulatory T cells exceeding levels associated with clinical benefit in third-party clinical trials across multiple autoimmune diseases -PT101 maintained selectivity for regulatory T cells at all doses tested -Phase 1a/2b clinical trial in ulcerative colitis expected to start mid-...